Summary. Using the isolated, perfused rat pancreas the importance of sulphydryl groups for the secretory process of insulin was investigated. It was found that ethacrynic acid (EA, 0.075-0.6 mmol/1) caused a dose-dependent, monophasic insulin release. Addition of EA to a glucose-stimulated (20 mmol/1) pancreas led to a sudden increase in hormone release, followed by a dose-dependent inhibition of release, which was not reversible after removal of EA. The same phenomenon was seen in the presence of 20mmol/1 leucine. Dithiothreitol (DTF, 0.1 and 1 mmol/1) had no effect on basal insulin secretion. Added to a glucose-stimulated pancreas DTF (1 mmol/1) caused a reversible inhibition of insulin release. The persistent inhibitory action of EA on glucose-induced insulin release could be reversed by simultaneous perfusion of EA and DTT. Sequential exposure of a glucose-stimulated pancreas to EA and DTT led to a rapid release of insulin, due to DTI'; however, the EA-induced inhibition of insulin secretion could not be prevented. Two kinds of thiol groups in the plasma membrane and in the beta cell might be responsible for the various kinetics of insulin release induced by EA and DTT. Ethacrynic acid (EA), another potent sulphydrylgroup blocking reagent, has been shown to prevent glyceryl-trinitrate-induced relaxation of smooth muscle, while dithiothreitol (DTT) has the opposite effect [7] . Since EA might also influence glucose tolerance, it is an interesting substance for further study of the role of SH-groups in the process of insulin secretion. Therefore, perfusions of isolated rat pancreas with each drug alone, with both drugs together and with the drugs in combination with glucose or leucine were performed.
The collecting tubes contained a small volume of pure bovine serum albumin (final concentration 0.65 g/100ml) to prevent insulin adsorption. The samples were stored at -20 ° C.
Insulin in the perfusate was determined by radioimmunoassay [10] , with minor modifications for semiautomatic analysis [11] . Human insulin was used as the standard, since human and rat insulin gave identical standard curves with the antibody used, provided that bovine serum albumin at the above concentration was added to the rat insulin standard samples. Glucose, leucine and EA did not affect the radioimmunoassay. However, as shown in Figure 1 , the immunoreactivity of insulin, stored at -20°C in a 
Results

Effect of EA on lnsulin Release
In the absence of glucose, EA induced a monophasic insulin release, which was most pronounced at the highest dose tested (Fig. 2) . Table 1 shows the dosedependency of the integrated insulin response during the first five minutes of exposure to EA. When EA was added during the second phase of glucose (20 mmol/1) -induced insulin release, an immediate dose-dependent burst of insulin secretion was followed by a dose-dependent inhibition of the glucose-stimulated insulin release (Fig. 3) . Very low concentration of EA (0.075 mmol/1) only caused a slow inhibition of glucose-provoked insulin release. The inhibition of insulin release was not reversible upon removal of EA, although the glucose perfusion was continued.
The same stimulatory and inhibitory phenomena were seen when leucine (20 retool/l) was present instead of glucose before, during and after exposure of the pancreas to 0.6 mmol/1 EA (Fig. 4) .
Effect of D TT on InsuEn Release
DTF (1 mmol/1) with or without substimulatory levels of glucose (3 mmol/1) did not cause any insulin release. After a preperfusion with 20 retool/1 glucose the addition of a low concentration of DTT (0.1 mmol/1) did not change the glucose-induced insulin release. In contrast 1 mmol/1 DTT led to a strong, but reversible, inhibition of the glucoseinduced insulin release ( 
Interaction of EA and DTT during Glucose-lnduced Insulin Release
When EA (0.12mmol/1) was added to a glucosestimulated pancreas a slow inhibition of insulin secretion occurred as described above (Fig. 3 and Fig. 6 ). Exchange of EA by 1 mmol/1 DTT caused a sudden burst of insulin release, followed by a complete, irreversible inhibition of glucose-induced insulin secretion.
Simultaneous addition of DTI7 and EA to a glucose-stimulated pancreas led to an immediate insulin release, which was followed by a transitory inhibition and a steady increase of insulin secretion, although EA plus DTT were still present in the perfusate (Fig. 7) . Upon removal of EA plus DTF, with con- 
Discussion
The importance of sulphydryl groups in secretory processes was first stressed by Douglas et al. [12] for vasopressin and by Schofield [13] for growth hormone. Our data indicate that binding of EA to sulphydryl groups at the cell membrane or inside the beta cell causes insulin release without the requirement of any substrate. Since the amount of insulin released is clearly dependent on the concentration of EA, it is possible that the number of sulphydryl groups blocked by alkylation is related to the amount of insulin released. The secretory mechanism induced by EA seems to be different from that provoked by glucose or leucine, since the secretion kinetics of these substances are quite different. EA, furthermore, induces an initial additive insulin release when perfused together with glucose or leucine.
The enhancement of insulin release upon addition of EA with or without glucose or leucine might be due to conformational changes of the beta-cell membrane caused by the binding of EA to SHgroups in the plasma membrane. This might induce sudden changes in ionic fluxes across the membrane resulting in depolarization of the beta-cell and insulin release. An increase in the permeability of the betacell membrane for monovalent cations after binding of organic mercurials inducing similar insulin secretory profiles has been found by Sehlin and Thljedal [14] . This change in transmembrane ionic fluxes might influence the activity of a NaK-ATPase demonstrated in islets [15, 16] . SH-group blocking agents like p-(chloromercuri)benzenesulphonic acid (p-CMBS) also directly influence ATPase activity [15] . It is therefore conceivable that EA may increase the insulin secretory capacity in a way similar to that of ouabain.
The slow inhibitory action of EA on insulin secretion may be due to a slow penetration of this drug into the beta cell, where it probably binds to SH groups of enzymes of glycolysis and oxidative phosphorylation, as demonstrated in cell free preparations [17, 18] and in intact cells [19] [20] [21] . Slow penetration into the beta-cell could be measured for other SH-groups blocking agents [5, [22] [23] [24] . The persistence of inhibition after removal of EA might be due to a long-lasting inhibition of the energy metabolism in the islets due to covalently bound EA to SHgroups of key enzymes in intermediary metabolism. The same kind of double action discussed for EA has been found by Hellman et al. for iodoacetamide [3] .
Stabilization of SH-groups or reduction of disulphide bridges at the beta-cell membrane by dithiothreitol did not cause insulin release by itself. This is in agreement with a study conducted with other thiols [6] . Addition of DTT to a glucose-stimulated pancreas led to an abrupt but reversible inhibition of insulin secretion. That this inhibition is reversible, although DTF is still present, might indicate that a new equlhbrium between sulphydryl groups and disulphides is reached which seems necessary for insulin release [23] . Hellman et al. reported that thiols, like reduced glutathione or 1-thio-D-glucose, potentiated glucose-provoked insulin secretion, while another thiol reagent was inert [6] . The potentiating effect was, however, only seen at a concentration of 0.1 mmol/1 and not at 0.5 mmol/1. Since we could not demonstrate any effect of DTI" at low concentration (0.1 mmol/1) and a marked inhibitory action at 1 mmol/1 our results do not confirm those of Hellman et al. [6] . This disagreement is, besides the completely different experimental conditions and the different reducing capacity of the thiols used in both studies, not readily explained.
That more than simple oxidation and reduction of SH-groups is involved in the actions of EA and DTT is shown in the experiments in which EA and DT-F are perfused in sequence or in combination. DTY, when added together with EA, provoked a sudden burst of insulin release, which was followed first by an inhibition and later by a deinhibition of insulin release. Comparable interaction of DT]? and EA was found by Ferrendelli et al. [25] who reported that the suppression of the adenylate cyclase activity in brain homogenates by EA could be fully restored by DTF, but only when added before or simultaneously with EA.
In the experiments in which glucose plus EA was followed by glucose plus DT-F a rapid release phase again occurred, but now DTI" was unable to prevent the EA-induced inhibition of stimulated insulin release. The sudden insulin release in both sets of experiments is probably due to rapid changes in the redox state of SH-groups in the plasma membrane.
The succeeding inhibition and deinhibition phenomena might reflect transport and intracellular binding of EA and DT]?. DTF when added together with EA might prevent EA entry into the cell and thereby block the inhibitory action of EA on intermediary metabolism or it might prevent alkylation of free SH-groups in the membrane or the cytosol. As soon as SH-groups are alkylated by EA, DTF, added afterwards, is unable to reverse this binding.
